4//SEC Filing
Valamehr Bahram 4
Accession 0001193125-26-010352
CIK 0001434316other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:03 PM ET
Size
5.4 KB
Accession
0001193125-26-010352
Insider Transaction Report
Form 4
Valamehr Bahram
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-01-09$1.07/sh−5,190$5,557→ 329,708 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell-to-cover" transactions and were not made at the discretion of the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $1.055 to $1.085 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Signature
/s/ Cindy Tahl, as Attorney-in-Fact|2026-01-12
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001748177
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:03 PM ET
- Size
- 5.4 KB